Skip to main content
SpringerLink
Log in
Book cover

Cardiology Consult Manual pp 419–433Cite as

Chemotherapy, Cardiovascular Disease, and Cardiac Tumors

  • Chapter
  • First Online:

  • 1125 Accesses

Abstract

Cardiac disease and cancer are the two most common medical conditions in the developed world. The rates of death for heart disease and malignant neoplasms remain very high. As we age, they tend to coexist. Cancer can affect the heart as metastasis, or due to the complexity of the heart, cancer can directly emanate from within the heart as a benign growth or malignant neoplasm. As cancer treatments have become more and more successful over the years, it is important to realize that some of these advances have led to increased cardiovascular morbidity and mortality due to the development of unintended cardiac side effects. This chapter summarizes chemotherapeutic and radiotherapeutic interventions most commonly associated with cardiovascular disease (CVD), recommendations for surveillance monitoring, possible treatments, and cardiac tumors that the general cardiologist should be aware of during routine consultation and office-based care.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Oeffinger KC, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.

    Article  CAS  PubMed  Google Scholar 

  2. Meinardi MT, et al. Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev. 1999;25:237–47.

    Article  CAS  PubMed  Google Scholar 

  3. Albini A, et al. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102:14–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Boerman LM, et al. Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population. Support. Care Cancer. 2014;22:1949–58.

    CAS  Google Scholar 

  5. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339:900.

    Article  CAS  PubMed  Google Scholar 

  6. Guglin M, Aljayeh M, Saiyad S, et al. Introducing a new entity: chemotherapy-induced arrhythmia. Europace. 2009;11:1579.

    Article  PubMed  Google Scholar 

  7. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996;125:47.

    Article  CAS  PubMed  Google Scholar 

  8. Steinberg JS, Cohen AJ, Wasserman AG, et al. Acute arrhythmogenicity of doxorubicin administration. Cancer. 1987;60:1213.

    Article  CAS  PubMed  Google Scholar 

  9. Barrett-Lee PJ, Dixon JM, Farrell C, et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol. 2009;20:816.

    Article  CAS  PubMed  Google Scholar 

  10. Bovelli D, Plataniotis G, Roila F, On behalf of the ESMO Guidelines Working Group. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21:277–82.

    Article  Google Scholar 

  11. MInotti G, et al. Anthracyclines. In: Offermanns S, Rosenthal W, editors. Encyclopedia of molecular pharmacology, vol. 1. 2nd ed: Springer; 2008.

    Google Scholar 

  12. Takimoto CH, Calvo E. Principles of oncologic pharmacotherapy. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer management: a multidisciplinary approach. 11th ed. London, UK: UBM Medica; 2008.

    Google Scholar 

  13. Lenneman CG, Sawyer DB. Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res. 2016;118(6):1008–20.

    Article  CAS  PubMed  Google Scholar 

  14. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672–7.

    Article  CAS  PubMed  Google Scholar 

  15. Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G, Rubino M, Veglia F, Fiorentini C, Cipolla CM. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20.

    Article  CAS  PubMed  Google Scholar 

  16. Force T, Krause DS, Van Etten RA. Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer. 2007;7:332–44.

    Article  CAS  PubMed  Google Scholar 

  17. Chen MH, Kerkela R, Force T. Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation. 2008;118:84–95.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86:1697.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Schwartz RG, Jain D, Storozynsky E. Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively. J Nucl Cardiol. 2013;20:443–64.

    Article  PubMed  Google Scholar 

  20. Storozynsky E. Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity. Futur Cardiol. 2015;11(4):421–4.

    Article  CAS  Google Scholar 

  21. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893–911.

    Article  PubMed  Google Scholar 

  22. Bruce CJ. Cardiac tumours: diagnosis and management. Heart. 2011;97(2):151–60.

    Article  PubMed  Google Scholar 

  23. Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027e31.

    Google Scholar 

  24. Piazza N, Chughtai T, Toledano K, et al. Primary cardiac tumours: eighteen years of surgical experience on 21 patients. Can J Cardiol. 2004;20:1443e8.

    Google Scholar 

  25. Vander Salm TJ. Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg. 2000;12:89.

    Article  CAS  PubMed  Google Scholar 

  26. Elbardissi AW, Dearani JA, Daly RC, et al. Embolic potential of cardiac tumors and outcome after resection: a case-control study. Stroke. 2009;40:156.

    Article  PubMed  Google Scholar 

  27. Sheu CC, Lin SF, Chiu CC, et al. Left atrial sarcoma mimicking obstructive pulmonary disease. J Clin Oncol. 2007;25:1277.

    Article  PubMed  Google Scholar 

  28. Engberding R, Daniel WG, Erbel R, et al. Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. European Cooperative Study Group. Eur Heart J. 1993;14:1223.

    Article  CAS  PubMed  Google Scholar 

  29. Dujardin KS, Click RL, Oh JK. The role of intraoperative transesophageal echocardiography in patients undergoing cardiac mass removal. J Am Soc Echocardiogr. 2000;13(12):1080–3.

    Article  CAS  PubMed  Google Scholar 

  30. de Lucas EM, Pagola MA, Fernández F, et al. Primary cardiac lymphoma: helical CT findings and radiopathologic correlation. Cardiovasc Intervent Radiol. 2004;27:190.

    PubMed  Google Scholar 

  31. Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics. 1999;19:1421.

    Article  CAS  PubMed  Google Scholar 

  32. Hoey ET, Mankad K, Puppala S, et al. MRI and CT appearances of cardiac tumours in adults. Clin Radiol. 2009;64:1214.

    Article  CAS  PubMed  Google Scholar 

  33. Siripornpitak S, Higgins CB. MRI of primary malignant cardiovascular tumors. J Comput Assist Tomogr. 1997;21:462.

    Article  CAS  PubMed  Google Scholar 

  34. Wintersperger BJ, Becker CR, Gulbins H, et al. Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography, and echocardiography. Eur Radiol. 2000;10:443.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Joseph Cardiology Department, St. Joseph Hospital, Bangor, ME, USA

    Jims Jean-Jacques

  2. University of Rochester Medical Center/Cardiology, Rochester, NY, USA

    Eugene Storozynsky

Authors
  1. Jims Jean-Jacques
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugene Storozynsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA

    Hanna Z. Mieszczanska

  2. Division of Cardiovascular Medicine-EP section, SUNY Downstate Medical Center, Brooklyn, NY, USA

    Adam S. Budzikowski

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jean-Jacques, J., Storozynsky, E. (2018). Chemotherapy, Cardiovascular Disease, and Cardiac Tumors. In: Mieszczanska, H., Budzikowski, A. (eds) Cardiology Consult Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-89725-7_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-89725-7_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-89724-0

  • Online ISBN: 978-3-319-89725-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation